https://pharmadog.xyz/news/587731 pharmadog en 2026-10-24T17:00:59.000Z Amgen and AstraZeneca present new combo data for extensive-stage small cell lung cancer at ESMO https://pharmadog.xyz/news/587411 pharmadog en 2026-10-24T16:00:12.000Z AstraZeneca, Lilly and Bayer unveil new strategies at ESMO 2026 in Madrid https://pharmadog.xyz/news/587075 pharmadog en 2026-10-24T14:30:56.000Z Amgen's Imdelltra plus AstraZeneca's Imfinzi cuts death risk by 58% in small cell lung cancer Phase 3 trial https://pharmadog.xyz/news/586339 pharmadog en 2026-10-24T11:00:00.000Z Christina Applegate’s misdiagnosis highlights ongoing challenges in multiple sclerosis diagnosis https://pharmadog.xyz/news/586340 pharmadog en 2026-10-24T11:00:00.000Z Opinion reflects on Theranos failures and the impracticality of its testing model https://pharmadog.xyz/news/586295 pharmadog en 2026-10-24T10:00:25.000Z Merck and Moderna present Phase 3 cancer vaccine data at ESMO26 amid Treasury proposal on China investment https://pharmadog.xyz/news/586438 pharmadog en 2026-10-24T06:25:00.000Z Merck and Moderna disclose phase 3 cancer vaccine data early after leak, showing improved recurrence-free survival with Keytruda https://pharmadog.xyz/news/584123 pharmadog en 2026-10-23T23:15:09.000Z Swiss biotech Windward Bio files for Nasdaq IPO to raise funds for China-derived assets and R&D https://pharmadog.xyz/news/583388 pharmadog en 2026-10-23T19:16:37.000Z ADA admits unclear policies after ejecting members, sparks boycott and journal shutdown https://pharmadog.xyz/news/583111 pharmadog en 2026-10-23T18:55:12.000Z Patient dies in Bristol Myers Squibb autoimmune CAR-T trial, raising safety concerns https://pharmadog.xyz/news/583112 pharmadog en 2026-10-23T18:48:10.000Z Few European-approved cancer drugs deliver high clinical benefit, analysis shows https://pharmadog.xyz/news/583067 pharmadog en 2026-10-23T18:36:40.000Z Bristol Myers Squibb identifies cause of safety signal in lupus CAR‑T trial https://pharmadog.xyz/news/582923 pharmadog en 2026-10-23T17:00:09.000Z BMS reports fatal septic pneumonia in MS patient during CAR T trial of zolacabtagene autoleucel https://pharmadog.xyz/news/582943 pharmadog en 2026-10-23T16:47:31.000Z Novartis MS drug remibrutinib cuts relapse rates by about a third in Phase 3 trials https://pharmadog.xyz/news/582944 pharmadog en 2026-10-23T16:39:04.000Z Writer empathizes with Christina Applegate’s MS misdiagnosis, recalling her own 13-year diagnostic journey https://pharmadog.xyz/news/582627 pharmadog en 2026-10-23T15:59:07.000Z Callio Therapeutics appoints Chris Hassig as chief scientific officer, coming from Boundless Bio https://pharmadog.xyz/news/582628 pharmadog en 2026-10-23T15:48:21.000Z STAT honors late infectious disease reporter Helen Branswell on The Readout LOUD podcast https://pharmadog.xyz/news/582795 pharmadog en 2026-10-23T15:33:00.000Z RNAi developers see surge in IPOs and funding as industry interest revives https://pharmadog.xyz/news/582607 pharmadog en 2026-10-23T15:27:30.000Z Alnylam to launch pivotal Huntington’s trial after early study shows strong huntingtin knockdown https://pharmadog.xyz/news/582629 pharmadog en 2026-10-23T15:24:28.000Z Tango’s pancreatic cancer combo shows striking promise at ESMO, building on Revolution Medicines’ earlier success https://pharmadog.xyz/news/582608 pharmadog en 2026-10-23T15:21:21.000Z Tango Therapeutics reports 82% response rate for vopimetostat plus Rasonque in pancreatic cancer, down from 92% earlier https://pharmadog.xyz/news/582583 pharmadog en 2026-10-23T15:13:11.000Z Lycia Therapeutics raises $317.5 million in IPO as Merck halts sac-TMT trial https://pharmadog.xyz/news/582584 pharmadog en 2026-10-23T15:03:52.000Z Roche signs up to $813M deal with Zymeworks for preclinical trispecific T cell engager https://pharmadog.xyz/news/134233 pharmadog en 2026-10-23T14:55:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/582331 pharmadog en 2026-10-23T14:52:20.000Z Roche warns Germany faces last chance to regain pharma investment confidence https://pharmadog.xyz/news/582351 pharmadog en 2026-10-23T14:47:21.000Z States Challenge New Medicaid Work Requirements in Boston Court https://pharmadog.xyz/news/582307 pharmadog en 2026-10-23T14:33:54.000Z Bristol Myers reports patient death in autoimmune CAR-T trial and explains summer pause https://pharmadog.xyz/news/582163 pharmadog en 2026-10-23T13:54:57.000Z Marengo's bispecific antibody invikafusp alfa shows tumor shrinkage in 8 cancer types in Phase 2 https://pharmadog.xyz/news/582164 pharmadog en 2026-10-23T13:54:40.000Z US proposes new biotech investment limits on China, but licensing deals remain allowed https://pharmadog.xyz/news/582183 pharmadog en 2026-10-23T13:45:14.000Z Personalized mRNA vaccine cuts melanoma recurrence risk by 42% in trial https://pharmadog.xyz/news/582165 pharmadog en 2026-10-23T13:40:08.000Z FDA lifts hold on Aardvark Therapeutics' ARD-101 after safety study shows no cardiac events https://pharmadog.xyz/news/582139 pharmadog en 2026-10-23T13:00:57.000Z Pathos AI secures $237M Series E funding at $3B valuation, partners with Bristol Myers on neuroscience https://pharmadog.xyz/news/582140 pharmadog en 2026-10-23T13:00:44.000Z US Treasury proposes rule that could bar biotech investments in China https://pharmadog.xyz/news/582141 pharmadog en 2026-10-23T13:00:17.000Z Biotech M&A slows sharply in Q3 as deal activity cools https://pharmadog.xyz/news/582015 pharmadog en 2026-10-23T13:00:00.000Z AI drug developer Pathos secures $237 million Series E, valuation hits $3 billion https://pharmadog.xyz/news/581995 pharmadog en 2026-10-23T11:58:39.000Z Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager https://pharmadog.xyz/news/581803 pharmadog en 2026-10-23T11:35:00.000Z Warp Sciences raises $215 million Series A to apply AI in drug building-block design https://pharmadog.xyz/news/581804 pharmadog en 2026-10-23T11:30:14.000Z Tango combo clears Rasonque bar and Takeda's Innovent sees early returns as ESMO data leaks dampen hype https://pharmadog.xyz/news/582558 pharmadog en 2026-10-23T11:23:00.000Z Gilead agrees to pay $1.275 billion upfront for PepStar’s oral IL‑23 inhibitor, targeting J&J’s Icotyde https://pharmadog.xyz/news/581805 pharmadog en 2026-10-23T11:00:34.000Z Voyager Therapeutics CEO Al Sandrock to resign next year, remains on board; Insmed appoints Paul Hudson as director https://pharmadog.xyz/news/581806 pharmadog en 2026-10-23T11:00:15.000Z Star Therapeutics raises $200 million to build new drug pipeline after Vega and Electra wins https://pharmadog.xyz/news/582647 pharmadog en 2026-10-23T11:00:00.000Z Star raises $200 million after successful spinouts of Electra and Vega Therapeutics https://pharmadog.xyz/news/581679 pharmadog en 2026-10-23T10:30:00.000Z Tango Therapeutics reports 82% tumor response in combo trial for advanced pancreatic cancer https://pharmadog.xyz/news/582560 pharmadog en 2026-10-23T10:22:00.000Z Bolt Biotherapeutics to acquire Prana Therapies in reverse merger, secured $120M financing https://pharmadog.xyz/news/582874 pharmadog en 2026-10-23T10:21:00.000Z Roche's Genentech reports 43% reduction in kidney damage marker in phase 3 IgA nephropathy trial https://pharmadog.xyz/news/582114 pharmadog en 2026-10-23T08:50:00.000Z Takeda’s ADC arcotatug tavatecan shows survival benefit in phase 3 gastric cancer trial https://pharmadog.xyz/news/581240 pharmadog en 2026-10-23T08:30:00.000Z Family reflects on extra months gained from new pancreatic cancer drug daraxonrasib https://pharmadog.xyz/news/581239 pharmadog en 2026-10-23T08:30:00.000Z Lung cancer patient credits targeted therapy for 15-year survival, notes limited benefit for others https://pharmadog.xyz/news/581238 pharmadog en 2026-10-23T08:30:00.000Z STAT reporters share reactions to new Elizabeth Holmes documentary https://pharmadog.xyz/news/581237 pharmadog en 2026-10-23T08:30:00.000Z Opioid Overdose Deaths Have Plummeted, Experts Call for Deeper Investigation https://pharmadog.xyz/news/581235 pharmadog en 2026-10-23T08:30:00.000Z State officials scramble to roll out Medicaid work requirements, exchange strategies at NAMD conference https://pharmadog.xyz/news/581236 pharmadog en 2026-10-23T08:30:00.000Z New Medicare rules could restrict pain medication access for many patients, doctor warns https://pharmadog.xyz/news/581023 pharmadog en 2026-10-23T07:45:51.000Z Alnylam to launch larger study of RNA therapy for Huntington’s disease https://pharmadog.xyz/news/581067 pharmadog en 2026-10-23T07:45:00.000Z Alnylam's experimental Huntington's therapy reduces mutant protein in early trial https://pharmadog.xyz/news/582879 pharmadog en 2026-10-23T06:59:00.000Z EQT to acquire Qiagen in €10.8 billion deal https://pharmadog.xyz/news/581778 pharmadog en 2026-10-23T04:27:00.000Z Roche pays $55 million upfront to Zymeworks for global rights to trispecific antibody ZW209 targeting small-cell lung cancer https://pharmadog.xyz/news/580075 pharmadog en 2026-10-23T02:02:41.000Z Gilead agrees to pay $1.28 billion upfront to China's PepStar for oral IL-23 inflammation drug candidate https://pharmadog.xyz/news/579971 pharmadog en 2026-10-23T01:37:00.000Z Lycia Therapeutics raises $318 million in IPO to fund protein degrader programs https://pharmadog.xyz/news/584029 pharmadog en 2026-10-23T00:00:00.000Z Experts urge cultural shift and standards to unlock real-world evidence potential in medtech https://pharmadog.xyz/news/584030 pharmadog en 2026-10-23T00:00:00.000Z Drug safety group petitions FDA to block marketing of unapproved compounded peptides; bipartisan bill seeks clinical trial reforms https://pharmadog.xyz/news/579507 pharmadog en 2026-10-22T23:12:17.000Z Gilead Sciences to Pay $45 Million to Settle Texas Medicaid Kickback Allegations https://pharmadog.xyz/news/580218 pharmadog en 2026-10-22T23:00:00.000Z US Treasury proposes COINS Act rules that restrict biotech investment in China but leave big pharma licensing deals untouched https://pharmadog.xyz/news/579586 pharmadog en 2026-10-22T22:59:00.000Z Natural Grocers recalls 2‑pound organic mung beans over possible glass contamination https://pharmadog.xyz/news/579127 pharmadog en 2026-10-22T21:57:11.000Z US Treasury drafts rules to curb American investment in Chinese biotech firms https://pharmadog.xyz/news/579043 pharmadog en 2026-10-22T21:04:40.000Z Merck and Moderna cancer vaccine data leak shows modest benefit, shares slide https://pharmadog.xyz/news/578851 pharmadog en 2026-10-22T20:00:07.000Z Pfizer and Valneva report mixed results for Lyme disease vaccine, with one analysis narrowly missing efficacy https://pharmadog.xyz/news/578707 pharmadog en 2026-10-22T19:48:07.000Z AbbVie’s HS drug lutikizumab meets Phase 3 goal but falls short of analyst expectations https://pharmadog.xyz/news/579250 pharmadog en 2026-10-22T19:42:00.000Z WinCo Foods recalls hoagie rolls after undisclosed sesame ingredient